Approval · Notice of Compliance 8966 · 2007
ESTROPLAN INJECTION: Notice of Compliance 8966
Issued August 10, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8966
- Date
- August 10, 2007
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESTROPLAN INJECTION | 02298406 | Marketed |
Medicinal ingredients
- CLOPROSTENOL SODIUM 250 MCG per ML